• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT FX DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number D-EVOLUTFX-2329
Device Problems Difficult or Delayed Positioning (1157); Device Dislodged or Dislocated (2923)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/06/2024
Event Type  malfunction  
Event Description
Medtronic received information that during implant of this 29 millimeter (mm) transcatheter bioprosthetic valve (j084159), three deployment attempts were made as the valve consistently dislodged into the left ventricle.The valve was recaptured two times due to deep implant position.It was also reported that another 29 mm valve (j084155) was had a bent valve crown.Subsequently a 34 mm valve was used and was implanted.A procedural delay of approximately 5 minutes was reported.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Continuation of d10: product id evolutfx-29 (serial: (b)(6)); product type: 0195-heart valves; implant date ; explant date product id evolutfx-34 (serial: (b)(6)); product type: 0195-heart valves; implant date 2024-03-06; explant date product id evolutfx-29 (serial: (b)(6) ); product type: 0195-heart valves; implant date ; explant date product id l-evolutfx-2329 (lot: 0012021824); product type: 0195-heart valves; implant date ; explant date medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Updated data: b5.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information as received that a misload was identified on the delivery catheter system (dcs) that was used with the valve that had the bent crown.The misloaded dcs was not used for implant, and a new dcs was used.The misload was not due to a new valve loader.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Event description continuation of d10: product id safari (lot number: ); product type: guidewire; product id d-evolutfx-2329 (lot: 0012045195); product type: 0195-heart valves; product id d-evolutfx-2329 (lot: ); product type: 0195-heart valves; device and method code additional codes - imf health impact and img component codes medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Additional information was received that during the valve implant, the deployment starting point was 3-5 millimeter (mm) below the pigtail on the non-coronary cusp (ncc).After the valve dislodged, the implant depth was greater than 10 mm.A non-medtronic guidewire (safari) was used.While loading of the 29 mm valve (j084155), the bent valve crown was visually observed during loading and the valve was not used.Subsequently the larger 34 mm valve was used as the 29 mm valve kept dislodging into the left ventricle.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX DCS
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18896487
MDR Text Key337697381
Report Number2025587-2024-01618
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/02/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberD-EVOLUTFX-2329
Device Catalogue NumberD-EVOLUTFX-2329
Device Lot Number0012045195
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/06/2024
Initial Date FDA Received03/13/2024
Supplement Dates Manufacturer Received03/13/2024
03/20/2024
Supplement Dates FDA Received03/20/2024
04/02/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H11...; SEE H11...
Patient Age68 YR
Patient SexMale
-
-